Evicenter
P&T meetings

Bezuclastinib

Nonadvanced systemic mastocytosis

Manufacturer
Cogent Biosciences
Regulatory submission
NDA submitted December 2025
Last updated
62 sources

Product information and disease descriptionProduct description

Product information

17 evidence topics · 11 sources

Average sales price and wholesale acquisition cost

Not applicable.

Contraindications/Warnings/Precautions/Adverse effects
Warnings and precautions

Not applicable.

Special populations

No evidence found.

Effect of Bezuclastinib on quality measures
Bezuclastinib-specific quality-measure findings

No evidence found.